Antimicrobial Susceptibility Test Market to Hit USD 5.7 Billion by 2032 | Key Players: Thermo Fisher, Bio-Rad, BD, Beckman Coulter

The global antimicrobial susceptibility test (AST) market is projected to grow from USD 3.28 billion in 2022 to USD 5.71 billion by 2032, expanding at a CAGR of 5.7%, according to recent research by Fact.MR. The market's robust growth trajectory is driven by the rising prevalence of infectious diseases, increasing antimicrobial resistance, and growing investments in diagnostic technologies across healthcare systems.

Antimicrobial susceptibility testing is vital in determining the most effective treatment against bacterial and fungal infections, helping reduce antimicrobial resistance-a growing global health threat. The increasing use of broad-spectrum antibiotics and evolving microbial strains are intensifying the need for accurate diagnostic tools such as AST.

Browse Full Report: https://www.factmr.com/report/4334/antimicrobial-susceptibility-test-market

Kits, Reagents & Consumables Dominate the Market
The kits, reagents & consumables segment is expected to remain the leading product category throughout the forecast period, accounting for over 58% of market share. This is attributed to their recurring demand, wide application in laboratories, and ongoing product innovations by major players.

Within the product landscape, disk diffusion methods continue to lead, representing 28.4% of the market in 2022. This method is highly favored for its cost-effectiveness, flexibility, and reliability in identifying bacterial susceptibility to antibiotics.

Regional Insights: North America and Europe Hold Major Shares

North America remains the dominant market, holding nearly 35% of global market share as of 2021. The region's growth is supported by a well-established healthcare system, a high number of diagnostic laboratories, and widespread awareness about antimicrobial resistance. The presence of key players such as BD, Thermo Fisher Scientific, and Beckman Coulter further enhances regional growth.

In Europe, the market accounted for 31.1% of global share in 2021. The region benefits from strong governmental support, advanced healthcare infrastructure, and initiatives to combat infectious disease outbreaks. Rising antibiotic resistance rates and healthcare funding programs continue to push demand for reliable AST solutions.

East Asia, led by countries such as Japan and China, is also emerging as a high-potential region with a forecast CAGR of 4.7% during 2022-2032. Growth is driven by expanding clinical laboratories and increasing investment in healthcare innovation.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4334

Competitive Landscape: Strategic Collaborations and Product Innovation

The antimicrobial susceptibility test market is moderately consolidated, with the top five companies accounting for around 23.6% of the global market. Key players include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company (BD), Beckman Coulter (Danaher Corporation), HiMedia Laboratories, and Alifax Holding S.p.A.

These companies are actively pursuing mergers, acquisitions, and strategic partnerships to expand their product portfolios and enhance their global footprint:

In April 2022, bioMérieux acquired Specific Diagnostics, a move aimed at reinforcing its position in antimicrobial resistance diagnostics and strengthening its rapid testing capabilities.
In August 2022, BD entered into a global commercial collaboration with Accelerate Diagnostics, Inc. to jointly address the growing threat of antimicrobial resistance with rapid diagnostic testing solutions.

Product innovation remains a core strategy, with companies focusing on automated and smart AST devices to deliver faster, more accurate results while reducing manual error.

Market Drivers: Infections, Resistance, and R&D

The growing incidence of microbial infections, including diseases caused by Salmonella, Shigella, and drug-resistant bacteria, is pushing healthcare providers to adopt AST in routine diagnostics. According to Fact.MR, antimicrobial resistance is responsible for over 2 million infections annually in the U.S. alone, highlighting the urgency of effective diagnosis and treatment.

Increased R&D spending in pharmaceutical development, particularly for novel antibiotics, is also driving demand for AST in drug discovery and clinical research. Governments and global health organizations are actively funding initiatives to promote innovation in this field.

Challenges: Cost and Regulation

Despite its advantages, market growth is tempered by challenges such as the high cost of automated AST systems and strict regulatory frameworks that increase development and approval timelines. Smaller healthcare facilities may face hurdles in adopting these technologies due to limited budgets and skilled workforce availability.

Outlook: A Resilient and Growing Market

With global health systems under increasing pressure to respond to emerging infectious diseases and the spread of antimicrobial resistance, the antimicrobial susceptibility test market is positioned for consistent growth through 2032. Investment in next-generation diagnostic technologies, combined with government support and public awareness, will be key to unlocking the full potential of this essential healthcare tool.

Check out More Related Studies Published by Fact.MR:

CSPG2 Antibody (Versican) Market
https://www.factmr.com/report/2663/cspg2-antibody-versican-market
B-Glucuronidase Enzymes Market
https://www.factmr.com/report/2668/b-glucuronidase-enzymes-market
Ambient Temperature Gel Permeation Chromatography Market
https://www.factmr.com/report/2673/ambient-temperature-gel-permeation-chromatography-market
Cell-Free Fetal DNA Testing Market
https://www.factmr.com/report/2679/cell-free-fetal-dna-testing-market

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.